Dysregulation of the Phosphatidylinositol 3-Kinase Pathway in Thyroid Neoplasia

John E. Paes, Matthew D. Ringel

Research output: Contribution to journalReview articlepeer-review

87 Scopus citations

Abstract

The phosphatidylinositol 3-kinase (PI3K) signaling pathway is an important regulator of many cellular events, including apoptosis, proliferation, and motility. Enhanced activation of this pathway can occur through several mechanisms, such as inactivation of its negative regulator, phosphatase and tensin homolog deleted on chromosome ten (PTEN), and activating mutations and gene amplification of the gene encoding the catalytic subunit of PI3K (PIK3CA). These genetic abnormalities have been particularly associated with follicular thyroid neoplasia and anaplastic thyroid cancer, suggesting an important role for PI3K signaling in these disorders. In this article, the role of PI3K pathway activation in thyroid cancer is discussed, with a focus on recent advances.

Original languageEnglish
Pages (from-to)375-387
Number of pages13
JournalEndocrinology and Metabolism Clinics of North America
Volume37
Issue number2
DOIs
StatePublished - Jun 2008

Fingerprint

Dive into the research topics of 'Dysregulation of the Phosphatidylinositol 3-Kinase Pathway in Thyroid Neoplasia'. Together they form a unique fingerprint.

Cite this